Drug recall · April 24, 2024
Atovaquone Oral Suspension USP recall
Why: Microbial contamination of a non-sterile product: potential Bacillus cereus contamination.
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Atovaquone Oral Suspension USP, 750 mg per 5 mL sachets, 20 Units x 5 mL cartons, Rx Only, Manufactured for: AvKARE, Pulaski, TN 38478, NDC 50268-086-12.
- Lots / codes
Lot: AW0221A Exp. 08/30/2025
- Quantity
- 153 cartons
- Company
- AvKARE, Pulaski, TN
- Distribution
- US Nationwide.
- Initiated
- March 28, 2024 · Voluntary: Firm initiated
- Classified
- April 16, 2024
- Reported
- April 24, 2024
- Ended
- August 23, 2024
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Atovaquone
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.